Success Story: NIW Approval Secured for Molecular Biology Research Advancing Drug Discovery for Metabolic Diseases
Client’s Testimonial:
"Thank you very much for your support throughout my I-140 NIW petition. I am truly grateful for your guidance and assistance during this process."
On July 28th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Japan
State of Residence at the Time of Filing: Florida
Approval Notice Date: July 28th, 2026
Processing Time: 31 months, 15 days (Premium Processing Upgrade Requested)
Case Summary:
A Research Vision with National Importance
The client successfully obtained approval of an I-140 National Interest Waiver (NIW) petition without receiving a Request for Evidence. Holding a Ph.D. in molecular biology, the client proposed to continue research focused on identifying drug targets for metabolic diseases, with a particular emphasis on fatty liver diseases, to accelerate drug discovery and improve therapeutic interventions. At the time of filing, the client was conducting molecular biology research at a research hospital and planned to continue investigating RNA biology and liver diseases through advanced experimental and genomic approaches. The petition demonstrated that this work addresses an important area of biomedical research with clear implications for public health and future therapeutic development.
Demonstrating a Strong Research Foundation
Rather than relying on academic qualifications alone, the petition established that the client was well positioned to continue advancing this nationally important work. The record included 4 peer-reviewed journal articles, including 1 first-authored publication, documenting original research in molecular biology. In addition, the client's publications had accumulated 49 citations, reflecting that independent researchers had relied upon these findings in subsequent investigations. Instead of treating the citation count as decisive by itself, the petition explained that the continued use of the client's work by other scientists illustrated the practical value and scientific influence of the research within the broader molecular biology community.
Evidence of Scientific Impact
The petition further highlighted how the client's research had contributed to a better understanding of molecular mechanisms involved in metabolism, liver function, stem cell biology, and appetite regulation. By showing that other researchers incorporated these findings into their own work, the petition demonstrated that the client's contributions had extended beyond individual publications and had helped advance ongoing scientific progress. This pattern of independent reliance provided meaningful evidence that the client possessed the expertise and record of achievement necessary to continue pursuing the proposed endeavor successfully.
Competitive Research Support
Another important component of the petition was evidence that the client's research had received funding from the Japan Society for the Promotion of Science (JSPS). Competitive research funding of this nature supported the argument that the client's work had already been recognized for its scientific value and potential. Rather than presenting funding as an accomplishment by itself, the petition explained that such support reflected confidence in the significance of the research and its contribution to advancing knowledge in molecular biology and metabolic disease research.
A Successful NIW Outcome
By combining evidence of advanced academic training, a focused research plan, scholarly publications, independent citations, competitive research funding, and demonstrated influence within the field, the petition established that waiving the job offer and labor certification requirements would benefit the United States. USCIS approved the client's NIW petition without an RFE, recognizing that the client was well positioned to continue conducting research that supports future advances in drug discovery and therapeutic development for metabolic diseases.